NxStage Establishes Annual Zenith Award To Recognize Excellence in Acute Renal Care

LAWRENCE, Mass., Jan. 20, 2015 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the creation of its annual Zenith Award to recognize acute renal care teams for their outstanding contributions to patient care. The award recipient will be announced on April 15, 2015 at a NxStage sponsored event during the 2015 AACN National Teaching Institute Critical Care Exposition in San Diego, California.

Interested participants are encouraged to submit an application for review by March 31, 2015 online at www.nxstage.com/zenith. Applicants are asked to detail specific examples of their creative, and effective, contributions to acute renal therapy services.

"The ICU teams administering therapy to a patient with acute kidney failure are critical to that patient's potential health and well-being," said Joe Turk, President of NxStage. "The Zenith Award is a much deserved recognition for the teams that dedicate their lives to continuously improving acute renal therapy with innovative solutions, and ultimately bettering patient care."

NxStage has provided renal replacement therapy solutions to ICUs for acute kidney injury since 2002. The NxStage® System One^tm is used in 7 of the top 10 leading renal care hospitals, as ranked by U.S. News and World Report.¹ The System One is designed to simplify the delivery of renal care, while providing clinicians with the flexibility to individualize therapy for their patients in the ICU. 

About NxStage

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.

Forward-Looking Statements 

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Reference: 1. U.S. News Best Hospitals Data: Nephrology. 2014-2015. Available at: http://health.usnews.com/best-hospitals/rankings/nephrology  

Contact:
Kristen Sheppard
[e-mail]

Logo - http://photos.prnewswire.com/prnh/20110503/MM94799LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nxstage-establishes-annual-zenith-award-to-recognize-excellence-in-acute-renal-care-300022580.html

SOURCE NxStage Medical, Inc.

Copyright 2015 PR Newswire